FeaturedNeurologyNeuroscience·March 27, 2021·4 min readCommon Alzheimer’s Treatment Linked to Slower Cognitive DeclineCholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.Read More
FeaturedNeurosciencePsychology·June 5, 2019·2 min readAlzheimer’s therapy may help overcome opioid addictionGalantamine, a medication used to treat Alzheimer's disease, shows promise in helping break opioid addiction.Read More
FeaturedOpen Neuroscience ArticlesPsychology·February 18, 2016·5 min readAlzheimer’s Drug Could Help Smokers QuitAccording to a new study, acetylcholinesterase inhibitors commonly used to help treat Alzheimer's disease appear to help smokers reduce cigarette consumption.Read More
FeaturedNeuroscience·May 7, 2013·3 min readTurning Alzheimer’s Fuzzy Signals Into High DefinitionResearchers have discovered how cholinesterase inhibitors, a class of drug that prevents the breakdown of acetylcholine, could sharpen the brain's performance in patients with Alzheimer's disease.Read More